Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Molecular Diagnostics Receives CLIA Certification

NEW YORK, March 31 (GenomeWeb News) - CombiMatrix Molecular Diagnostics has received CLIA certification to operate as a clinical laboratory, the company announced today.

 

Matt Watson, CEO of CMDX, said his company had been working to establish processes and procedures that would meet CLIA's quality control and quality assurance standards since it opened in May 2005.

 

CMDX is a wholly owned subsidiary of CombiMatrix, which is a unit of Acacia Research.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.